SPDR S&P Biotech ETF
129 hedge funds and large institutions have $1.68B invested in SPDR S&P Biotech ETF in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 55 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
36% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 55
42% less call options, than puts
Call options by funds: $51.9M | Put options by funds: $90M
Holders
129
Holding in Top 10
2
Calls
$51.9M
Puts
$90M
Top Buyers
| 1 | +$102M | |
| 2 | +$15.6M | |
| 3 | +$6.04M | |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$4.69M |
| 5 |
LCS
Levin Capital Strategies
New York
|
+$2.87M |
Top Sellers
| 1 | -$30.6M | |
| 2 | -$11.5M | |
| 3 | -$7.15M | |
| 4 |
TH
Timber Hill
Greenwich,
Connecticut
|
-$5M |
| 5 |
Jane Street
New York
|
-$2.73M |